Track 2-1: Cancer Epidemiology, Biostatistics and Prevention

Session Chair

Dr. Jeffrey T. Holt, Professor of Pathology, Commonwealth Medical College, Scranton PA, USA

Session Co-Chair

Call for Co-host

13:30-13:50

Title: Personalized Genetic Medicine: Scientific Rational Therapy Based on BRCA Gene Knowledge
Dr. Jeffrey T. Holt, Professor of Pathology, Commonwealth Medical College, Scranton PA, USA

13:50-14:10

Speech Opportunity Available

14:10-14:30

Speech Opportunity Available

14:30-14:50

Title: Telomere and Cancer: Cause or Consequence?
Dr. Lifang Hou, Assistant Professor, Department of Preventive Medicine, Northwestern University, USA

14:50-15:10

Speech Opportunity Available

15:10-15:25

Coffee Break

15:25-15:45

Title: Vitamin D Receptor Genes Polymorphisms and Risk for BCC Development
Dr. Joanna Narbutt, Department of Dermatology, Medical University of Lodz, Poland

15:45-16:05

Title: TBD
Dr.  Aleksandra Lesiak, Department of Dermatology Medical University of Lodz, Poland

16:05-16:25

Title: Epidemiology and Risk Factors Associated with Hepatocellular Carcinoma in a Mediterranean Population
Dr Polyxeni Agorastou, Scientific Associate Gastenterology, Aristoteleion University of Thessaloniki, Greece

16:25-16:45

Title: Use of Natural Compounds for the Control of Tumor Development
Dr. Krishna P. Gupta, Assistant Director, Carcinogenesis Laboratory, Indian Institute of Toxicology Research M. G. Marg, India

16:45-17:05

Panel Discussion
3-4 Topics will be Proposed by Session Chair

Track 2-2: Molecular and Cell Oncology

Session Chair

Dr. Hui-Kuan Lin, Assistant Professor, Department of Molecular and Cellular Oncology, University of Texas M.D. Anderson Cancer Center, USA

Session Co-Chair

Dr. Wael M. ElShamy, Assistant Professor of Pathology, John A. Burns School of Medicine, University of Hawaii and Cancer Research Center of Hawaii, USA

13:30-13:50

Title: Parent Essential Fatty Acids (PEOs), Oxygenation, and Cancer Prevention: A New Epigenetic Solution
Dr. Brian Scott Peskin, Professor, Chief Research Scientist, Cambridge International Institute for Medical Science, USA

13:50-14:10

Title: PDLIM4, a Tumor Suppressor, is Epigenetically Regulated by C-Myc in Prostate Cancer Cells
Dr. Charles Y. F. Young, Professor, Department of Urology, Biochemistry and Molecular Biology, Mayo Clinic College of Medicine, USA

14:10-14:30

Title: Loss of Cell Polarity and Primary Cilia Dislocation Plays a Role in Centrosome and Cell Cycle Abnormalities in Breast and Prostate Cancer Progression
Dr. Heide Schatten, Professor, Editor, Microscopy and Microanalysis, Department of Veterinary Pathobiology, University of Missouri-Columbia, USA

14:30-14:50

Speech Opportunity Available

14:50-15:10

Title: Regulation of Akt Signaling Activation by Ubiquitination
Dr. Hui-Kuan Lin, Assistant Professor, Department of Molecular and Cellular Oncology, University of Texas M.D. Anderson Cancer Center, USA

15:10-15:25

Coffee Break

15:25-15:45

Speech Opportunity Available

15:45-16:05

Title: Targeting of Novel Molecules to Inhibit Breast Cancer Metastasis
Dr. Wael M. ElShamy, Assistant Professor of Pathology, John A. Burns School of Medicine, University of Hawaii and Cancer Research Center of Hawaii, USA

16:05-16:25

Title: Activin A Signaling in Prostate Cancer Progression
Dr. Hong-Yo Kang, Associate professor, Graduate Institute of Clinical Medical Sciences, Chang Gung Memorial Hospital, Chang Gung University, College of Medicine, Taiwan

16:25-16:45

Speech Opportunity Available

16:45-17:05

Panel Discussion
3-4 Topics will be Proposed by Session Chair

Track 2-3: Cancer Genomics, Genetics, Epigenetics and System Biology

Session Chair

Dr. Chas Bountra, Head of Structural Genomics Consortium, Chief Scientist, Unit Director, Member of congregation and Group Head / PI, Structural Genomics Consortium, University of Oxford, UK

Session Co-Chair

Call for Co-host

8:30-8:50

Title: Novel Epigenetic Proteins as Targets for Cancer Therapy
Dr. Chas Bountra, Head of Structural Genomics Consortium, Chief Scientist, Unit Director, Member of congregation and Group Head / PI, Structural Genomics Consortium, University of Oxford, UK

8:50-9:10

Speech Opportunity Available

9:10-9:30

Title: Retrotransposon, L1, the Culprit for Tumorigenesis in Genomics
Dr. Yunfeng Zhu, Professor, Affiliated Hospital in Academy of Military Medical Sciences, China

9:30-9:50

Title: Epigenetic and Cancer
Dr. Igor P. Pogribny, Associate Professor, Division of Biochemical Toxicology, National Center for Toxicological Research, USA

9:50-10:10

Speech Opportunity Available

10:10-10:25

Coffee Break

10:25-10:45

Speech Opportunity Available

10:45-11:05

Title: Antineoplastic Efficacy vis-à-vis Molecular Mechanism of Action of a Novel Synthetic Drug Pt – ATP on Experimental Animal Models
Dr. Kalyan K Mukherjea, Professor, Department of Chemistry, Jadavpur University, India

11:05-11:25

Title: Three DNA Methylation Epigenotypes Of Colorectal Cancer
Dr. Atsushi Kaneda, Associate Professor, Genome Science Division, RCAST, The University of Tokyo, Japan

11:25-11:45

Speech Opportunity Available

11:45-12:05

Panel Discussion
3-4 Topics will be Proposed by Session Chair

Track 2-4: Hematology-Oncology

Session Chair

Call for Host

Session Co-Chair

Dr. Allan S.Y. Lau, Professor of Paediatrics, Cytokine Biology Group; Professor of Pharmacology and Pharmacy, LKS Faculty of Medicine, The University of Hong Kong, China

Speech Opportunity Available

Speech Opportunity Available

Title: Mechansims Underlying Epstein-Barr Virus Lmp-1-Induced Cytokine Dysregulation And Their Effects On Evasion Of Immune Response
Dr. Allan S.Y. Lau, Professor of Paediatrics, Cytokine Biology Group; Professor of Pharmacology and Pharmacy, LKS Faculty of Medicine, The University of Hong Kong, China

Title: Total Marrow Irradiation (Tmi) for Hematological Malignancies
Dr. Susanta K Hui, Associate Professor, Therapeutic Radiology Faculty member-Biomedical Engineering, Biophysical Sciences and Medical Physics, University of Minnesota, USA

Track 2-5: Neuro-Oncology

Session Chair

Call for host

Session Co-Chair

Dr. Faris Farassati, Associate Professor of Medicine, Department of Medicine, The University of Kansas Medical School, USA

13:30-13:50

Speech Opportunity Available

13:50-14:10

Title: Overactivation Of Ral As A Therapeutic Target In Neurological Malignancies
Dr. Faris Farassati, Associate Professor of Medicine, Department of Medicine, The University of Kansas Medical School, USA

14:10-14:30

Title: Primary Research on Brain Tumor Stem Cells and their Application for Immunotherapy
Dr. Xiaodan Jiang, Professor, Neurosurgery Institute of Guangdong, Zhujiang Hospital, Southern Medical University, China

14:30-14:50

Title: Anti-Oncogenic Potential of Dipeptidyl Peptidase-Iv in Human Glioblastoma
Dr Aleksi Sedo, Professor, Head of the Institute of Biochemistry and Experimental Oncology, Faculty of Medicine of Charles University, Czech Republic

14:50-15:10

Speech Opportunity Available

15:10-15:30

Title: MicroRNA-124a: A Master Regulator Of Glioblastoma Migration
Dr. Kerrie McDonald, Research Fellow, Head Cerebral Research, Cancer Genetics, Kolling Institute of Medical Research, Australia

Track 2-6: Tumor Virology

Session Chair

Call for host

Session Co-Chair

Call for Co-host

15:25-15:50

Speech Opportunity Available

15:50-16:15

Speech Opportunity Available

16:15-16:40

Title: Human Endogenous Retroviruses as Biomarkers of Early Breast Cancer
Dr. Gary Johanning, Associate Professor, Department of Veterinary Sciences and Carcinogenesis at the University of Texas M. D. Anderson Cancer Center, USA

16:40-17:05

Title: Role of Dietary Factors in the HPV-Induced Cervical Carcinogenesis
Dr. Chandrika J. Piyathilake, Associate Professor, Department of Nutrition Sciences, University of Alabama at Birmingham, UK

17:05-17:30

Speech Opportunity Available

Track 2-7: Tumor Immunology and Immunotherapy（Part I）

Session Chair

Dr. T.-C. Wu, Professor, Departments of Pathology, Oncology, Obstetrics and Gynecology and Molecular Microbiology and Immunology, The Johns Hopkins Medical Institutions, USA

Session Co-Chair

Dr. Sara I. Pai, Assistant Professor, Otolaryngology-Head & Neck Surgery and Head and Neck Cancer Research Division, Johns Hopkins Hospital, USA

8:30-8:50

Title: Antigen Specific Cancer Immunotherapy for Gynecological Malignancies
Dr. T. C. Wu, Professor, Departments of Pathology, Oncology, Obstetrics and Gynecology and Molecular Microbiology and Immunology, The Johns Hopkins Medical Institutions, USA

8:50-9:10

Speech Opportunity Available

9:10-9:30

Title: Anti-CD44 Antibody Therapy Inhibits Pancreatic Cancer Metastasis and Post-Radiotherapy Recurrence
Dr. Wenhua Tang, Lab Manager, University of Michigan Comprehensive Cancer Center, USA

9:30-9:50

Speech Opportunity Available

9:50-10:10

Title: Characterization of the Tumor Microenvironment of Human Papilloma Virus Associated Head and Neck Cancers
Dr. Sara I. Pai, Assistant Professor, Otolaryngology-Head & Neck Surgery and Head and Neck Cancer Research Division, Johns Hopkins Hospital, USA

10:10-10:25

Coffee Break

10:25-10:45

Title: Combining TLR Agonists and Cell Costimulation Eradicates Established Tumors in Mice
Dr. Michael H. Kershaw, Associate Professor, Laboratory Head Cancer Immunotheraphy Research, Peter MacCallum Cancer Centre, Australia

10:45-11:05

Title: Optimal Control of Mixed Immunotherapy and Chemotherapy of Cancers Using Mathematical Techniques
Dr. Weiqing Gu, Associate Professor, Math-in-Industry Clinic Program Director, and Professor of Mathematics, Harvey Mudd College, USA

11:05-11:25

Title: Chemotherapy Enhances Antigen-specific Immunity of Cancer Vaccine through Anti-angiogenesis and Suppressing Regulatory T Lymphocytes
Dr. Wen-Fang Cheng, Associate Professor, National Taiwan University Hospital, Taiwan

11:25-11:45

Speech Opportunity Available

11:45-12:05

Panel Discussion
3-4 Topics will be Proposed by Session Chair

Track 2-7: Tumor Immunology and Immunotherapy（Part II）

Session Chair

Dr. J Schlom, Head, Immunotherapeutics Group, Laboratory of Tumor Immunology and Biology, the National Institutes of Health (NIH), USA

Session Co-Chair

Dr. RO Dillmann, Medical and Scientific Director, Hoag Cancer Center, Newport Beach, USA

13:30-13:50

Title: Immunotherapy to Renal and Prostate Cancer
Dr. J Schlom, Head, Immunotherapeutics Group, Laboratory of Tumor Immunology and Biology, the National Institutes of Health (NIH), USA

13:50-14:10

Title: Multipeptides in Cancer Therapy
Dr. G Parmiani, Professor, Department of Oncology, San Raffaele. Scientific Institute, Italy

14:10-14:30

Title: Dendritic Cells as Cancer Vaccine
Dr. RO Dillmann, Medical and Scientific Director, Hoag Cancer Center, Newport Beach, USA

14:30-14:50

Title: Cancer Biotherapy
Dr. F Belardelli, Director of the Department of Cell Biology and. Neurosciences, Istituto Superiore di Sanita, Italy

14:50-15:10

Title: Particulate Structures as Immunotherapeutic Strategies
Dr. L Buonaguro, Professor, Molecular Biology and Viral Oncology, Department of Experimental Oncology, Istituto Nazionale Tumori Fond Pascale(INT), Italy

15:10-15:30

Coffee break

15:30-15:50

Title: Immunotherapy in Head and Neck Squamous Cell Carcinoma Cells
Dr. S Ferrone, Professor, Department of Immunology, Roswell Park Cancer Institute, USA

15:50-16:10

Title: Role of TLR in cancer immunotherapy
Dr. T Seya, Professor, Department of Immunology, Osaka Medical Center for Cancer and Cardiovascular Diseases, Japan

16:10-16:30

Title: TBD
Dr. FM Marincola, Laboratory Head, Department of Transfusion Medicine, Clinical Center, National Institutes of Health, USA

16:30-16:50

Title: Modulation of Dendritic Cell Machinery for Optimized Antigen Presentation
Dr. B Gao, Director Institute of Microbiology & Epidemiology, Chinese Academy of Sciences, China

16:50-17:10

Title: Transfer of Effector Cells as Antitumor Approach
Dr. SA Rosenberg, Postdoctoral Fellow, Department of Health and Human Services. the National Institutes of Health (NIH), USA

17:10-17:30

Panel Discussion
3-4 Topics will be Proposed by Session Chair

Track 2-8: Cancer/Tumor Adhesion, Migration, Invasion, and Metastasis

Session Chair

Dr. Shuen-Kuei Liao, Professor, Graduate Institute of Clinical Medical Sciences, Chang Gung University, Taoyuan, Taiwan

Session Co-Chair

Call for Co-host

8:30-8:50

Title: Molecular Events Associated with Epithelial-Mesenchymal Transition of Nasopharyngeal Carcinoma in the Absence of Epstein-Barr Virus Genome
Dr. Shuen-Kuei Liao, Professor, Graduate Institute of Clinical Medical Sciences, Chang Gung University, Taoyuan, Taiwan

8:50-9:10

Speech Opportunity Available

9:10-9:30

Title: Pterostilbene Inhibits TPA-induced Invasion and Metastasis of Human Hepatoma Cells through Inactivating PKC, MAPK and PI3K/Akt Signal Transduction Pathway
Dr. Min-Hsiung Pan, Professor, Department of Seafood Science, National Kaohsiung Marine University, Taiwan

9:30-9:50

Speech Opportunity Available

9:50-10:10

Speech Opportunity Available

Coffee Break

10:25-10:45

Speech Opportunity Available

10:45-11:05

Title: Essential Role of FAK Signaling for Cancer Invasion by Tnf-Alpha And Il-1-Beta
Dr. Takeshi Senga, Associate professor, Division of Cancer Biology, Nagoya University school of Medicine, Japan

11:05-11:25

Title: TRIM16 Acts as a Tumour Suppressor in Neuroblastoma and Skin Cancer
Dr. Belamy B Cheung, Cancer Institute NSW Research Fellow, Project Leader/Conjoint Lecturer UNSW, Molecular Carcinogenesis Program, Children’s Cancer Institute Australia for Medical Research, Australia

11:25-11:45

Title: Effect of Pentoxifylline, A Haemorheological Agent, on Adhesion, Proliferation and Invasion in B16f10 Melanoma
Dr. R. P. Gude, Principal Investigator, Cancer Research Institute ACTREC,Tata Memorial Centre, India

11:45-12:05

Panel Discussion
3-4 Topics will be Proposed by Session Chair

Track 2-9: Tumor Microenvironment and Therapy

Session Chair

Call for Host

Session Co-Chair

Dr. Günter J. Hämmerling, Professor, Division of Molekulare Immunologie, Cancer Research Center, DKFZ, Germany

13:30-13:50

Title: Control of Tumor Immunity by the Mircroenvironment
Dr. Günter J. Hämmerling, Professor, Division of Molekulare Immunologie, Cancer Research Center, DKFZ, Germany

13:50-14:10

Title: The Role Of The Microenvironment In Regulating Chemokine-Directed Cellular Dissemination From Solid Tumors
Dr. Jonathan Blay, Scientific Director, Beatrice Hunter Cancer Research Institute; Professor of Pharmacology, Department of Pharmacology, Dalhousie University, Canada

14:10-14:30

Speech Opportunity Available

14:30-14:50

Speech Opportunity Available

14:50-15:10

Title: Physiologic Parameters in the Milieu of Solid Tumors Have the Potential to Indicate their Sensitivity to Chemotherapeutic Agents
Dr. Saminathan S. Nathan, Associate Professor, NUS Musculoskeletal Oncology Research Laboratory, Singapore

15:10-15:30

Coffee Break

Track 2-10: Chromatin Regulation and Cancers

Session Chair

Dr. Woojin An, Assistant Professor, USC Norris Comprehensive Cancer Center, USA

Session Co-Chair

Dr. Ben O. de Lumen, Professor, Nutritional Sciences & Toxicology, University of California, USA

13:30-13:50

Keynote Speech:
Title: Chromatin Modifications and Histone Code in Stem Cell Cells and Cancer Stem Cells
Dr. Zdenko Herceg, Head, Epigenetics Group International Agency for Research on Cancer (IARC), France

13:50-14:10

Speech Opportunity Available

14:10-14:30

Title: Lunasin: A Cancer Preventive Seed Peptide that Modifies Chromatin
Dr. Ben O. de Lumen, Professor, Nutritional Sciences & Toxicology, University of California, Berkeley, USA

14:30-14:50

Speech Opportunity Available

14:50-15:10

Speech Opportunity Available

15:10-15:25

Coffee Break

15:25-15:45

Title: Development and Characterization of Novel Pro-Apoptotic Peptides Derived from Histone N-Terminal Domains
Dr. Woojin An, Assistant Professor, USC Norris Comprehensive Cancer Center, USA

15:45-16:05

Title: Histone Demethylase Gasc1 in Cancer
Dr. Zeng Quan Yang, Associate Professor, Karmanos Cancer Institute,Wayne State University, USA

16:05-16:25

Title: Mechanistic Links between Tip60, ATM and Histone Methylation Codes during DNA Repair
Dr. Brendan D. Price, Assistant Professor, Department of Radiation Oncology, Dana-Farber Cancer Institute, Harvard Medical School, USA

16:25-16:45

Speech Opportunity Available

16:45-17:05

Panel Discussion
3-4 Topics will be Proposed by Session Chair

Track 2-11: Hormones and Endocrinology in Oncology

Session Chair

Dr. Rajkumar Lakshmanaswamy, Director, Basic Science Research, Center of Excellence in Cancer Research, Paul L. Foster School of Medicine, Texas Tech University Health Sciences Center, USA

Session Co-Chair

Dr. Feng-Qi Zhao, Associate Professor, Animal Science, Mammary Gland Biology & Molecular Biology, The University of Vermont, USA

8:30-8:50

Title: Hormones: Prevention and Progression of Breast Cancer
Dr. Rajkumar Lakshmanaswamy, Director, Basic Science Research, Center of Excellence in Cancer Research, Paul L. Foster School of Medicine, Texas Tech University Health Sciences Center, USA

8:50-9:10

Speech Opportunity Available

9:10-9:30

Title: TBD
Dr. Feng-Qi Zhao, Associate Professor, Animal Science, Mammary Gland Biology & Molecular Biology, The University of Vermont, USA

9:30-9:50

Title: The Role of Cell Cycle Regulators in the Metabolic Control in Normal and Cancer Cells
Dr. Lluis Fajas, Research Director, Metabolism and Cancer Laboratory, Institut de recherches cliniques de Montréal, France

9:50-10:10

Speech Opportunity Available

10:10-10:25

Coffee Break

Track 2-12: Bioinformatics and Med-informatics in Cancer Research

Session Chair

Call for Host

Session Co-Chair

Call for Co-host

 Six Speakers' profiles will be released soon.

Track 2-13: Mechanisms of Resistance in Cancer Cells

Session Chair

Dr. Martin Michaelis, Dr. Institut für Medizinische Virologie, Klinikum der Goethe-Universität, Frankfurt am Main, Germany

Session Co-Chair

Dr. Wen Jin Wu, Principal Investigator, Division of Monoclonal Antibodies, FDA, USA

8:30-8:50

Speech Opportunity Available

8:50-9:10

Title: Mechanism of Trastuzumab Resistance of Human Breast Cancer Cells
Dr. Wen Jin Wu, Principal Investigator, Division of Monoclonal Antibodies, FDA, USA

9:10-9:30

Title: Studies to Understand and Overcome Chemoresistance Mechanisms in a Collection of Chemoresistant Cancer Cells
Dr. Martin Michaelis, Dr. Institut für Medizinische Virologie, Klinikum der Goethe-Universität, Frankfurt am Main, Germany

9:30-9:50

Title: Novel Roles of the Alternative NF-Kappab Pathway in Tumor Development
Dr. Véronique Baud, Group Leader, Institut Cochin, Université Paris Descartes, France

9:50-10:10

Speech Opportunity Available

10:10-10:25

Coffee Break

10:25-10:45

Speech Opportunity Available

10:45-11:05

Title: Molecular Aspects of Drug Resistance in Hepatocellular Carcinoma: Could MEK/ERK Targeting Regulate the Doxorubicin Chemosensitivity
Dr. Irena Manov, Senior Investigator, Pediatric Research and Electron Microscopy Unit, Rappaport Faculty of Medicine, Technion-Israel Institute of Technology, Israel

11:05-11:25

Speech Opportunity Available

11:25-11:45

Speech Opportunity Available

11:45-12:05

Panel Discussion
3-4 Topics will be Proposed by Session Chair

Track 2-14: Cancer Metastases Research

Session Chair

Call for host

Session Co-Chair

Call for Co-host

10:20-10:40

Speech Opportunity Available

10:40-11:00

Title: Role of the Microenvironment in Site-Specific Liver Metastasis
Dr. Pnina Brodt, Professor, Department of Surgery, Oncology and Medicine, McGill University Health Center, Canada

11:00-11:20

Title: Novel Regional Treatment Strategies for Unresectable Hepatic Malignancies Utilizing High Dose Chemotherapy
Dr. James F. Pingpank, Associate Professor of Surgery, Division of Surgical Oncology, UPMC Cancer Pavillion, USA

11:20-11:40

Title: Role of Portal Vein Embolisation in the Management of Colorectal Liver Metastases
Dr. Viniyendra Pamecha, Liver transplant and HPB Surgery, Royal Free Hospital and University College , UK

11:40-12:00

Title:  Employment of Quantitative Light Microscopy in Identification of a Novel Metastasis Suppressor, Protein 4.1b, Controlling Morphology, Motility, Chemotaxis and Invasion
Dr. Daniel Zicha, Cancer Research UK London Research Institute, Lincoln's Inn Fields Laboratories, UK

Track 2-15: Surgical Oncology

Session Chair

Call for host

Session Co-Chair

Dr. Rakhshanda Layeequr Rahman, Associate Professor, Surgical Oncology, Department of Surgery, Texas Tech University Health Sciences Center, USA

10:25-10:50

Speech Opportunity Available

10:50-11:15

Title: Real Usefulness of Technological Devices for a Safe Hepatic Surgery
Dr. Isidoro Di Carlo, Associate Professor, Department of Surgical Sciences, Organ Transplantation and Advanced Technologies, University of Catania, Italy

Track 2-16: Infectious Agents and Cancer

Session Chair

Dr. John Ziegler, Interim Director of Global Health Sciences Graduate Group, UCSF Global Health Sciences; Professor in Residence Emeritus, USA

Session Co-Chair

Dr. Franco M. Buonaguro, Editor-in-Chief, Head, Unit of Viral Oncogenesis and Immunotherapy, Istituto Nazionale Tumori(INT), Italy

8:30-8:50

Title: The Worldwide Burden of IAC
Dr. John Ziegler, Interim Director of Global Health Sciences Graduate Group, UCSF Global Health Sciences; Professor in Residence Emeritus, USA

8:50-9:10

Speech Opportunity Available

9:10-9:30

Title: Proteomics in IA-Related Cancers
Dr. Pierre Bedossa, Professor of pathology and Heads, Department of Pathology, Hôpital Beaujon, France; Director of the Research Unit on Liver Physiopathology, INSERM, University of Paris, France

9:30-9:50

Title: The Burden of IAC in the Middle East
Dr. Micha Barchana, Director, Israel National Cancer Registry, Israel

9:50-10:10

Title: The Burden of IAC in North Africa
Dr. Amal S. Ibrahim, Professor of Epidemiology, National Cancer Institute, Cairo University, Egypt

Coffee Break

10:25-10:45

Title: Global Serological Survey for Cancer-Related Pathogens
Dr. Robert Newton, Professor, Genetics Unit, Department of Health Sciences, University of York, UK

10:45-11:05

Title: Genomics in IA-Related Cancers
Dr. Franco M. Buonaguro, Editor-in-Chief, Head, Unit of Viral Oncogenesis and Immunotherapy, Istituto Nazionale Tumori(INT), Italy

11:05-11:25

Speech Opportunity Available

11:25-11:45

Title: The Burden of IAC in Sub-Sahara Regions
Dr. Sam Mbulateye, Investigator, Division of Cancer Epidemiology and Genetics, National Cancer Institute, USA

11:45-12:05

Panel Discussion
3-4 Topics will be Proposed by Session Chair